Potential Economic Benefits of Lower-Extremity Amputation Prevention Strategies in Diabetes
Daniel A. Ollendorf(Institute for Clinical and Economic Review), Gerry Oster(University of Washington Medical Center), James G. Kotsanos(Eli Lilly (United States)), Mark Friedman(Moffitt Cancer Center), Tamara Cooper(Eli Lilly (United States)), William J Wishner(Indiana University School of Medicine), Marisa A. Bittoni
Cited by 308
Related Papers
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2006|1.3k
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
|CHEST Journal|2002|1.3k
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
|Journal of Clinical Oncology|2001|682
Lifetime Health and Economic Consequences of Obesity
|Archives of Internal Medicine|1999|461